S-adenosylhomocysteine Accumulation Promotes Atherosclerosis by Epigenetic Regulation of Endoplasmic

来源 :第十二次全国动脉硬化性疾病学术会议 | 被引量 : 0次 | 上传用户:forcet
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aim S-adenosylhomocysteine (SAH) is involved in the epigenetic mechanism of hyperhomocysteinemia pathogenicity of atherosclerosis, but the underlying mechanisms remain unclear.Here, we tested the hypothesis whether SAH affects atherosclerosis via epigenetic regulation of endoplasmic reticulum stress pathways.Methods and Results Apolipoprotein E-deficient (ApoE-/-) mice at eight weeks of age were fed one of four diets for 16 weeks: control, high-methionine (10 g/kg food), adenosine periodate oxidized (40mg/kg food) (ADA, the inhibitor of SAH hydrolase to prevent cleavage of SAH to homocysteine and adenosine), or ADA combined methionine.ADA supplement significantly reduced the protein expression and activity of SAH hydrolase, and then elevated plasma SAH levels.Atherosclerotic lesion size was significantly increased in ADA or ADA combined methionine diet-fed mice compared with control mice.Correlation analyses showed that plasma SAH was linked with atherosclerotic lesion independent of plasma homocysteine.Expressions of endoplasmic reticulum stress markers (GRP78, CHOP) were significantly increased in the mice with elevated plasma SAH levels.Moreover, plasma SAH was associated with the inhibition of trimethylation of histone H3 lysine 9 (3meH3K9)Chromatin immunoprecipitation assay showed a decrease in levels of suppressor chromatin marker 3meH3K9 in the promoter regions of GRP78 and CHOP in the plasma SAH accumulated mice.Conclusion SAH accumulation promotes the development of atherosclerosis independent of plasma homocysteine by epigenetic regulation of endoplasmic reticulum stress pathways.
其他文献
目的 循环中鞘磷脂信号分子鞘氨醇-1-磷酸(S1P)主要富集于高密度脂蛋白(HDL)颗粒并对HDL功能产生重要影响.HDL上S1P来自何处并通过何种途径富集于HDL上对分析HDL功能具有重要意义.磷脂转运蛋白(PLTP)通过介导磷脂转运引起HDL重构及功能改变的分子机制很可能与S1P的转运有关.本研究采用液相-串联质谱(LC-MS/MS)检测C57BL/6小鼠(WT)和相同遗传背景下PLTP缺陷(
背景 家族性高胆固醇血症(FH)是一类严重脂质代谢紊乱的单基因显性遗传性疾病,其主要致病基因有低密度脂蛋白受体(LDLR)、载脂蛋白B100(ApoB100)、枯草溶菌素9(PCSK9)等六种致病基因.FH是早发冠心病的高危人群,早期明确诊断对于预防心血管病具有重要意义.由于缺乏高通量的筛查手段,在中国对于其基因诊断报道较少.北京安贞医院动脉硬化研究室与美国迈基诺公司共同研发FH致病基因靶向捕获芯
目的 拟观察G蛋白偶联受体120(GPR120)激活在肝X受体(LXR)诱导的肝脏脂肪性变中的作用,为防治脂代谢紊乱及相关疾病提供新线索。方法 将人肝癌细胞系HepG2进行如下分组:对照组、GW9508(GPR120的激动剂)处理组、T0901317处理组、GW9508预处理+T0901317处理组,酶学法测定细胞内甘油三酯水平;实时荧光定量PCR检测细胞SREBP1-c、SCD1、FAS mRN
目的 探讨银杏达莫注射液在冠状动脉缺血再灌注损伤治疗中的内在机制,进而能更好地为冠状动脉支架植入术后即阻塞血管再通后的血管内皮细胞的保护作用提供综合性的理论基础,为设计新的抗缺血再灌注治疗方案及开发有效的临床治疗药物提供科学依据.方法 采用人脐静脉内皮细胞(human vascular endothelial cells,HUVEC)体外传代培养方法,将HUVEC分为3组:正常组、缺氧再复氧组和银
目的 探讨成纤维细胞生长因子2(FGF-2)对大鼠缺血再灌注损伤心脏保护作用的新机制.方法 在Langendorff装置上建立大鼠离体心脏缺血再灌注(L/R)模型,40只SD大鼠随机分为6组,(1)缺血再灌注组(I/R组)(n=7):K-H液灌流平衡30min,接着K-H液再灌流5 min,停灌30 min,复灌60 min;(2)FGF-2组(n=7):在缺血再灌注组的基础上,复灌最初10 mi
背景和目的 已有报道显示,神经鞘磷脂合成酶2基因缺失(sphingomyelin synthase 2 knockout,SMS2-/-)有抗动脉粥样硬化及抗炎作用.本文以SMS2-/-小鼠为研究对象,旨在探讨神经鞘磷脂(sphingomyelin,SM)代谢与血清高密度脂蛋白(high-density lipoprotein,HDL)抗氧化、抗炎症、保护内皮能力之间的关系.方法 雄性28周龄SM
目的 趋化因子Chemerin是新发现的脂肪细胞因子,它可以诱导单核细胞衍生的树突状细胞及巨噬细胞跨血管内皮向炎症部位迁移聚集,发挥其在免疫炎症反应中的作用,而单核细胞黏附和跨内皮迁移在动脉粥样硬化(As)发病过程中具有极其重要的作用.血管旁脂肪组织是活跃的内分泌器官,其分泌的脂肪细胞因子由外向内与动脉管壁相互作用,直接影响As的发生发展.本课题通过体外实验研究冠状动脉旁脂肪组织分泌的Chemer
背景 家族性高胆固醇血症(FH)是一种常染色体显性遗传疾病,患者血浆胆固醇水平极度增高,动脉粥样硬化发展迅速,且多发生早发冠心病.FH主要是由低密度脂蛋白受体(LDLR)突变所致.LDLR是一种细胞表面糖蛋白,通过受体介导的内吞作用特异性结合并内吞合载脂蛋白B100 (ApoB100)或载脂蛋白E(ApoE)的脂蛋白,可将约70%的低密度脂蛋白胆固醇(LDLC)转入细胞.截至目前,世界范围内已报道
Aim To investigate the effects of ezetimibe on intracellular cholesterol level, and the mechanisms underlying the protective roles of ezetimibe against Chol: MβCD-induced cholesterol accumulation in v
Aim We are interested in developing a well-controlled mechanical injury thrombosis mouse model that involves pinching of the aorta with forceps.Methods In this study, we established two levels of aort